济南前列腺引起尿分叉济南一直中途疲软怎么办,济南得了阳痿可以治疗吗,济南治疗男性早泄医院,济南怎么才是射精无力,济南治阳痿不举的药,济南尿道灼烧刺痛,济南阴囊疼痛

The Trump administration is pushing back on a New York Times report that Education Secretary Betsy DeVos is looking into a plan that would allow states to use federal funding to buy firearms for teachers.On Wednesday, the Times reported that the Education Department was considering using a grant program called the Student Support and Academic Enrichment Program as a way to give federal funding for firearm purchases to states or school districts. The report cited multiple people with knowledge of the plan.A senior administration official told CNN that the idea laid out in the Times report did not originate with the Department of Education or DeVos. That official said the department received a letter from the Texas state Department of Education asking if the funds from a federal grant program could be used to purchase firearms. It was circulated to departmental lawyers and researchers for guidance, according to the official. The department ultimately chose not to respond, the official said.The official added that DeVos thinks that Congress should take action to clarify whether or not using the grant funding to buy guns is permissible. Moreover, the Education Department believes the grant program is intentionally vague to give school districts flexibility, and the idea of purchasing firearms was likely not considered when it was written, according to the official.In response to the Times report, Education Department spokeswoman Liz Hill told CNN that "the department is constantly considering and evaluating policy issues, particularly issues related to school safety. The secretary nor the department issues opinions on hypothetical scenarios."The discussion around arming teachers has been a deeply controversial one. President Donald Trump floated the proposal to arm educators and school staff on multiple occasions in the wake of the deadly school shooting at Marjory Stoneman Douglas High School in Parkland, Florida in February 2018."If you had a teacher who was adept with the firearm, they could end the attack very quickly," Trump said during a listening session on school safety a week after the shooting.The idea of arming school staff has been met with sharp condemnation.Former Congresswoman Gabrielle Giffords said in a statement Wednesday that "arming teachers is not a solution.""It recklessly puts American children in even more danger," she said in response to the Times report. "It's time for Americans to find the courage to take on the powerful and fight for our own safety."The American Federation of Teachers and the National Education Association also lambasted the proposal. Nicole Hockley, whose six-year-old son was killed in the 2012 Sandy Hook Elementary School shooting, took the microphone and told Trump she would rather arm teachers with ways to prevent shootings in the first place rather than with a firearm.Despite the criticism, Trump doubled down on the proposal on several subsequent occasions, and in March, the Trump administration proposed providing some school personnel with "rigorous" firearms training.In the wake of the Parkland shooting, the Trump administration also created a federal school safety commission, which is chaired by DeVos. In June, she testified before a congressional committee that the commission would not focus on looking at the role the role of guns in school safety. That stance was panned during a public forum. Democrats on the House Committee on Education and the Workforce have called on DeVos to explain how the commission will explore the role of guns."The Commission was charged with recommending policies and funding proposals to prevent school violence," 17 members of the committee wrote in a letter in June. "A core element of combating school violence is addressing gun violence, both in school and in our communities."The-CNN-Wire 3843

The US Food and Drug Administration expanded?the list of drugs being recalled that contain valsartan. The drug is used as a component in a set of drugs used to treat heart failure and blood pressure.New to the list are some valsartan products manufactured by Hetero Labs Ltd. in India, which are labeled as Camber Pharmaceuticals Inc. Test results show that some of the products may be tainted.The FDA announced a valsartan recall in July after lab tests revealed that some drugs could have been tainted with a substance linked to higher risk of cancer. The drug had been recalled in 22 other countries. The expanded recall includes some drugs that contain valsartan and hydrochlorothisazide. Not all of the drugs containing valsartan were affected.N-nitrosodimethylamine or NDMA, the impurity the lab tests found, is considered a?possible carcinogen by the US Environmental Protection Agency. It is an organic chemical that has been used to make liquid rocket fuel, and it can be unintentionally introduced through certain chemical reactions. It's a byproduct of the manufacturing of some pesticides and fish processing.The medicines that are now a part of this expanded list?in the recall are tablets sold by AvKare, A-S Medication Solutions LLC, Bryant Ranch Prepack Inc, Camber Pharmaceuticals, Inc. H J Harkins Company, Northwind Pharmaceuticals, NuCare Pharmaceuticals Inc., Prinston Pharmaceutical Inc. (labeled as Solco Healthcare LLC), Proficient Rx LP, Remedy Repack, Teva Pharmaceuticals (labeled as Major Pharmaceuticals), Teva Pharmaceuticals USA (labeled as Actavis).The FDA also published a list of valsartan products that are not currently recalled. Only the drugs suspected of being tainted with NDMA are on the recall list. If you are taking a valsartan drug, look for the company name on your prescription bottle. If the information isn't on the label, you can call your pharmacy for those details.The recalled medicine is linked to a manufacturer in China. The substances were supplied by Zhejiang Huahai Pharmaceuticals, based in Linhai, in eastern China, which said it notified authorities as soon as it identified the impurity."We published our recall notice at midday on July 13 in China and overseas, and published the US market recall notice on July 14 Beijing time ... all the drug materials for the Chinese market were recalled by July 23," the company said in a statement to the Shanghai stock exchange last month.The FDA said on its website that it's working with drug manufacturers "to ensure future valsartan active pharmaceutical ingredients are not at risk."If you are worried that your drug could be on the recall list, talk with your doctor or pharmacist before changing any routine with your medicine. Because not all valsartan drugs are involved in the recall, they might be able to switch you to a version of the drug made by another company.If you know your drug is on the recall list, the FDA suggests you continue taking it until your doctor or pharmacist provides a replacement.To get a sense of what taking a tainted drug could mean, FDA scientists estimated that if 8,000 people took the highest dose of valsartan (320 milligrams) from the recalled batches every day for four years, there may be one additional case of cancer."The key with this is, patients should not stop taking their medication abruptly, that definitely can be harmful," Dr. Mary Ann Bauman, a representative for the American Heart Association, said in July. "You don't want to jump to any conclusions on your own about this medication, or any medication for that matter. Definitely talk with your doctor first." 3690

The way doctors treat asthma in both children and adults just got a major update.Speaking to the Journal of the American Medical Association, respiratory experts said the changes in guidelines focus on six key areas, including improving asthma diagnosis, management, and treatment.It’s the first published update in 13 years.“So, one of the goals of our update was to address the issue of who can use intermittent inhaled corticosteroids and when used, are they as effective as daily use,” said Michelle M. Cloutier, MD with UConn Health.One of the biggest changes is that many patients may not need to use an inhaler every day anymore.“Especially those families of young children who don’t necessarily buy into using daily medication when their children are having intermittent symptoms,” said Stephanie Lovinsky-Desir, MD, MS with Columbia University Irving Medical Center.The new recommendations for inhaler use vary by age and severity of asthma, so it’s important to talk to your doctor about the new guidelines.Asthma affects nearly 5% of adults and 10% of children.During the pandemic, because of the higher death rate of asthma patients from COVID-19, more people have been seeking treatment for the condition.The average annual cost of asthma per person is more than ,200. But research has also shown among other things, regular use of medication and flu vaccines can reduce the chances of someone with asthma being hospitalized, driving up those costs. 1472

The woman who became internet famous in October for flipping the bird at President Donald Trump's motorcade, and then said she was subsequently fired, is suing her former employer for unlawful termination.Juli Briskman was fired from the marketing team at Akima LLC in November shortly after she volunteered that she was the one who had made the gesture in a photo that went viral, she said at the time."I thought that it would probably get back to my company eventually," Briskman said in an interview with CNN's Jeanne Moos.She said she was told she had violated the company's social media policy, and said the company in turn fired her.Briskman tweeted Wednesday that "I was fired from my job for flipping off @realDonaldTrump. Today, I filed suit with @GellerLawyers & @protctdemocracy because what happened to me was unlawful and un-American."Her attorney, Maria Simon, reiterated this point in a statement through the nonprofit Protect Democracy,"Juli's expression of disapproval of the President is fundamental political speech protected by both the United States Constitution and Virginia state law," she said. "Akima's actions -- forcing Juli to resign out of fear of unlawful retaliation by the government -- violated the basic tenets of Virginia employment law. Ms. Briskman chose in her private time and in her capacity as a private citizen to express her disapproval of President Trump by extending her middle finger."CNN has reached out to Akima LLC seeking comment. 1512

The Trump administration's executive order threatening to withhold funding from sanctuary cities is unconstitutional, a US appeals court said Wednesday.This story is developing. 190